Open AccessOutcome of Relapsed DLBCL Patients, Treated with Polatuzumab-BR or Polatuzumab-R: Real Life Data
Author(s) -
Yafit Segman,
Elena Ribakovsky,
Abraham Avigdor,
Vladimir Vainstein,
Neta Goldschmidt,
Shimrit Harlev,
Odit Gutwein,
Uri Abadi,
Anatoly Nemets,
Orit Sofer,
Najib Dally,
Kalman Filanovsky,
Merav Leiba,
Nadav Sarid,
Noam Benyamini,
Yair Herishanu,
Ron Ram,
Chava Perry,
Irit Avivi
Publication year - 2019
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood-2019-124164
Subject(s) - medicine , bendamustine , rituximab , diffuse large b cell lymphoma , oncology , tolerability , lymphoma , gastroenterology , adverse effect
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom